NDC 63020-049

VELCADE

Bortezomib

VELCADE is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Millennium Pharmaceuticals, Inc.. The primary component is Bortezomib.

• Product ID: 63020-049_0859677e-480a-4073-8900-6c69564143cb
• NDC: 63020-049
• Product Type: Human Prescription Drug
• Proprietary Name: VELCADE
• Generic Name: Bortezomib
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2003-05-13
• Marketing Category: NDA / NDA
• Application Number: NDA021602
• Labeler Name: Millennium Pharmaceuticals, Inc.
• Substance Name: BORTEZOMIB
• Active Ingredient Strength: 4 mg/1
• Pharm Classes: Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 63020-049-01

1 VIAL in 1 CARTON (63020-049-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

• Marketing Start Date: 2003-05-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63020-049-01 [63020004901]

VELCADE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA021602
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-05-13

NDC 63020-049-02 [63020004902]

VELCADE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA021602
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-11-19
• Marketing End Date: 2012-03-26

NDC 63020-049-03 [63020004903]

VELCADE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA021602
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2011-03-21
• Marketing End Date: 2012-03-26

NDC 63020-049-04 [63020004904]

VELCADE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA021602
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2012-03-26
• Marketing End Date: 2020-05-08

Drug Details

Active Ingredients

Ingredient	Strength
BORTEZOMIB	3.5 mg/1

OpenFDA Data

• SPL SET ID: 1521d321-e724-4ffc-adad-34bf4f44fac7
• Manufacturer:
  • Millennium Pharmaceuticals, Inc.
• UNII:
  • 69G8BD63PP
• RxNorm Concept Unique ID - RxCUI:
  • 402243
  • 402244

Pharmacological Class

• Proteasome Inhibitor [EPC]
• Proteasome Inhibitors [MoA]

Medicade Reported Pricing

63020004901 VELCADE 3.5 MG VIAL

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "VELCADE" or generic name "Bortezomib"

NDC	Brand Name	Generic Name
63020-049	VELCADE	bortezomib
0143-9098	bortezomib	bortezomib
0409-1700	Bortezomib	Bortezomib
0409-1703	BORTEZOMIB	BORTEZOMIB
0409-1704	BORTEZOMIB	BORTEZOMIB
10019-991	BORTEZOMIB	bortezomib
25021-244	BORTEZOMIB	BORTEZOMIB
50742-484	Bortezomib	Bortezomib
51817-586	Bortezomib	bortezomib
55150-337	BORTEZOMIB	BORTEZOMIB
60505-6050	BORTEZOMIB	bortezomib
63323-721	Bortezomib	Bortezomib
63323-821	Bortezomib	Bortezomib
67184-0530	Bortezomib	Bortezomib
68001-534	Bortezomib	Bortezomib
68001-540	Bortezomib	Bortezomib
68001-541	Bortezomib	Bortezomib
70511-161	Bortezomib	bortezomib
70511-162	Bortezomib	bortezomib
70710-1411	BORTEZOMIB	BORTEZOMIB
70771-1708	BORTEZOMIB	BORTEZOMIB
70860-225	Bortezomib	bortezomib
71288-118	Bortezomib	Bortezomib
72205-183	Bortezomib	Bortezomib
72266-243	Bortezomib	bortezomib
72266-244	Bortezomib	bortezomib